Our Publications
Show: AllPeer ReviewedNon Peer Reviewed
24 publications from 2014
McLaughlin, J., Surah, S., Synnott, C., Adams, R., Walsh, C., O'Dea, S., Noone, S., Keenan, E., Keating, S., Barry, M., Bergin, C., Mulcahy, F., Lyons, F., Health-related quality of life of patients on opiate replacement therapy, Heroin Addiction and Related Clinical Problems, 16, (4), 2014, p25-32
Mulgrew NM and Kettyle LM and Ramsey JM and Cull S and Smyth LJ and Mervyn DM and Bijl JJ and Thompson A, c-Met inhibition in a HOXA9/Meis1 model of CN-AML., Developmental dynamics : an official publication of the American Association of Anatomists, 2014
Kelly C and Yadav AB and Lawlor C and Nolan K and O'Dwyer J and Greene CM and McElvaney NG and Sivadas N and Ramsey JM and Cryan SA, Therapeutic aerosol bioengineering of siRNA for the treatment of inflammatory lung disease by TNFα gene silencing in macrophages., Molecular pharmaceutics, 2014
Kelly C and Lawlor C and Burke C and Barlow JW and Ramsey JM and Jefferies C and Cryan SA, High-throughput methods for screening liposome-macrophage cell interaction., Journal of liposome research, 2014
Ward, M.P. and Spiers, J.P., Serine/Threonine Protein Phosphatase regulation of Matrix Metalloproteinase 9 in Hepatocellular Carcinoma, WCP2014, Capetown South Africa, 2014
Ward, M.P. and Botting, C.H. and Lucitt, M.B. and Spiers, J.P., Identification of Phosphoproteins Regulated by Protein Phosphatase 2A Inhibition in Human Hepatocellular Carcinoma , Pharmacology 14, British Pharmacology Society, 2014
McCullagh LM, Tilson L, Adams R, Barry M, HTA Informed Price Negotiations: Cost Savings To The Health Payer in Ireland., 2014
Cooper JA, Ryan C, Smith SM, Wallace E, Bennett K, Cahir C, Williams D, Teeling M, Fahey T, Hughes CM; (The PROMPT Steering Group) , The development of the PROMPT (PRescribing Optimally in Middle-aged People's Treatments) criteria., BMC Health Services Research, 14, 2014, p13
Fogarty E, Walsh C, McGuigan C, Tubridy N, Barry M, Direct and Indirect Economic Consequences of Multiple Sclerosis in Ireland., Applied health economics and health policy, 2014
Scott KR, Power JD, McDermott SD, O'Brien JE, Talbot BN, Barry MG, Kavanagh PV, Identification of (2-aminopropyl)indole positional isomers in forensic samples., Drug testing and analysis, 6, (7-8), 2014, p598-606
Christie R, Horan E, Fox J, O'Donnell C, Byrne HJ, McDermott S, Power J, Kavanagh P, Discrimination of cathinone regioisomers, sold as 'legal highs', by Raman spectroscopy., Drug testing and analysis, 6, (7-8), 2014, p651-7
Bouso ED, Gardner EA, O'Brien JE, Talbot B, Kavanagh PV, Characterization of the pyrolysis products of methiopropamine., Drug testing and analysis, 6, (7-8), 2014, p676-83
Power JD, Barry MG, Scott KR, Kavanagh PV, An unusual presentation of a customs importation seizure containing amphetamine, possibly synthesized by the APAAN-P2P-Leuckart route., Forensic science international, 234, 2014, pe10-3
Welter J, Meyer MR, Kavanagh P, Maurer HH, Studies on the metabolism and the detectability of 4-methyl-amphetamine and its isomers 2-methyl-amphetamine and 3-methyl-amphetamine in rat urine using GC-MS and LC-(high-resolution)-MSn., Analytical and bioanalytical chemistry, 406, (7), 2014, p1957-74
Kavanagh PV, Power JD, New psychoactive substances legislation in Ireland - Perspectives from academia., Drug testing and analysis, 6, (7-8), 2014, p884-91
Power JD, Scott KR, Gardner EA, Curran McAteer BM, O'Brien JE, Brehon M, Talbot B, Kavanagh PV, The syntheses, characterization and in vitro metabolism of nitracaine, methoxypiperamide and mephtetramine., Drug testing and analysis, 6, (7-8), 2014, p668-75
Welter J, Kavanagh P, Maurer HH, GC-MS and LC-(high-resolution)-MS(n) studies on the metabolic fate and detectability of camfetamine in rat urine., Analytical and bioanalytical chemistry, 406, (16), 2014, p3815-29
Brandt SD, Baumann MH, Partilla JS, Kavanagh PV, Power JD, Talbot B, Twamley B, Mahony O, O'Brien J, Elliott SP, Archer RP, Patrick J, Singh K, Dempster NM, Cosbey SH, Characterization of a novel and potentially lethal designer drug (±)-cis-para-methyl-4-methylaminorex (4,4'-DMAR, or 'Serotoni')., Drug testing and analysis, 6, (7-8), 2014, p684-95
Power JD, O'Brien J, Talbot B, Barry M, Kavanagh P, The identification of an impurity product, 4,6-dimethyl-3,5-diphenylpyridin-2-one in an amphetamine importation seizure, a potential route specific by-product for amphetamine synthesized by the APAAN to P2P, Leuckart route., Forensic science international, 241, 2014, pe13-9
Wallach J, Kavanagh PV, McLaughlin G, Morris N, Power JD, Elliott SP, Mercier MS, Lodge D, Morris H, Dempster NM, Brandt SD, Preparation and characterization of the 'research chemical' diphenidine, its pyrrolidine analogue, and their 2,2-diphenylethyl isomers., Drug testing and analysis, 2014
Power JD, Kavanagh P, O'Brien J, Barry M, Twamley B, Talbot B, Dowling G, Brandt SD, Test purchase, identification and synthesis of 2-amino-1-(4-bromo-2, 5-dimethoxyphenyl)ethan-1-one (bk-2C-B)., Drug testing and analysis, 2014
O'Brien C, Fogarty E, Walsh C, Dempsey O, Barry M, Kennedy MJ, McCullagh L, The cost of the inpatient management of febrile neutropenia in cancer patients - a micro-costing study in the Irish healthcare setting. , European Journal of Cancer Care, 2014
J Svärd, F Blanco, D Nevin, D Fayne, F Mulcahy, M Hennessy and JP Spiers, DIFFERENTIAL INTERACTIONS OF ANTIRETROVIRAL AGENTS WITH LXR, ER AND GR NUCLEAR RECEPTORS - POTENTIAL CONTRIBUTING FACTORS OF ADVERSE EVENTS, British Journal of Pharmacology, 171, 2014, p480 - 497
Kennedy, A. Doherty , D.G Petrasca, A. Hennessy, M. Spiers, J.P., HIV-1 Tat clade-specific cytokine induction in monocytes/macrophages is not evidenced in total or Vγ9Vδ2 T lymphocytes, AIDS, 28, 2014, p131 - 133